CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 378 enrolled
Drug / intervention
Intravenous Access Device Flushingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05763147
NCT05763147N/ACompleted
CompareCT.gov

A Prospective, Multi-center, Randomized, Open Label, Controlled Trial of BD Pre-filled Flush Syringes

Becton, Dickinson and Company·interventional·Posted Mar 10, 2023·Updated Jul 30, 2024

In Brief

A clinical study evaluating Intravenous Access Device Flushing for Effectiveness and Safety of Pre-filled Flush Syringe. Completed, enrolled 378 participants across 3 sites.

Detailed Summary

This study is to compare the BD PosiFlush™ Pre-filled Flush Syringes (manufactured by BD, USA) and evaluate the effectiveness and safety of the pre-filled flush syringes (manufactured by Suzhou Becton Dickinson Medical Devices Co., Ltd.) for locking and flushing the end of catheter line in Chinese popluation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEffectiveness and Safety of Pre-filled Flush Syringe
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 10, 2023
Enrollment StartNov 3, 2022
Primary CompletionDec 26, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.3 years ago

Interventions

Intravenous Access Device Flushingdevice

locking and flushing the end of catheter line at the intervals of different drug treatment.